Respiri Limited
Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. It also provides critical patient health tracking services to clinicians and … Read more
Respiri Limited (RSHUF) - Net Assets
Latest net assets as of June 2024: $2.64 Million USD
Based on the latest financial reports, Respiri Limited (RSHUF) has net assets worth $2.64 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($6.19 Million) and total liabilities ($3.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.64 Million |
| % of Total Assets | 42.59% |
| Annual Growth Rate | -6.94% |
| 5-Year Change | 5.7% |
| 10-Year Change | -32.39% |
| Growth Volatility | 170.31 |
Respiri Limited - Net Assets Trend (1999–2024)
This chart illustrates how Respiri Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Respiri Limited (1999–2024)
The table below shows the annual net assets of Respiri Limited from 1999 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | $2.64 Million | +218.90% |
| 2023-06-30 | $826.89K | -72.51% |
| 2022-06-30 | $3.01 Million | -60.27% |
| 2021-06-30 | $7.57 Million | +203.44% |
| 2020-06-30 | $2.49 Million | +259.64% |
| 2019-06-30 | $-1.56 Million | -194.66% |
| 2018-06-30 | $1.65 Million | -8.16% |
| 2017-06-30 | $1.80 Million | -55.46% |
| 2016-06-30 | $4.04 Million | +3.48% |
| 2015-06-30 | $3.90 Million | -57.03% |
| 2014-06-30 | $9.08 Million | +459.44% |
| 2013-06-30 | $1.62 Million | -23.27% |
| 2012-06-30 | $2.11 Million | +0.22% |
| 2011-06-30 | $2.11 Million | -26.40% |
| 2010-06-30 | $2.87 Million | -27.04% |
| 2009-06-30 | $3.93 Million | -19.03% |
| 2008-06-30 | $4.85 Million | +101.72% |
| 2007-06-30 | $2.41 Million | +519.42% |
| 2006-06-30 | $388.37K | -74.30% |
| 2005-06-30 | $1.51 Million | +32.30% |
| 2004-06-30 | $1.14 Million | +220.25% |
| 2003-06-30 | $-949.92K | -168.85% |
| 2002-06-30 | $1.38 Million | -89.61% |
| 2001-06-30 | $13.28 Million | +74.83% |
| 2000-06-30 | $7.60 Million | -52.35% |
| 1999-06-30 | $15.94 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Respiri Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13846520400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $140.55 Million | 5329.86% |
| Other Comprehensive Income | $3.70 Million | 140.42% |
| Other Components | $1.00 | 0.00% |
| Total Equity | $2.64 Million | 100.00% |
Respiri Limited Competitors by Market Cap
The table below lists competitors of Respiri Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Woorim Machinery Co. Ltd
KQ:101170
|
$59.64 Million |
|
Moatable Inc
NYSE:MTBLY
|
$59.67 Million |
|
Alithya Group Inc
NASDAQ:ALYAF
|
$59.69 Million |
|
Prime Securities Limited
NSE:PRIMESECU
|
$59.72 Million |
|
OSE Immunotherapeutics S.A.
LSE:0RAD
|
$59.55 Million |
|
1st Colonial Bancorp Inc
PINK:FCOB
|
$59.55 Million |
|
TCI Express Limited
NSE:TCIEXP
|
$59.54 Million |
|
MetaTech AP
TWO:3224
|
$59.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Respiri Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 826,890 to 2,636,940, a change of 1,810,050 (218.9%).
- Net loss of 7,129,247 reduced equity.
- Share repurchases of 559,852 reduced equity.
- New share issuances of 8,808,757 increased equity.
- Other comprehensive income decreased equity by 3,077,103.
- Other factors increased equity by 3,767,495.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.13 Million | -270.36% |
| Share Repurchases | $559.85K | -21.23% |
| Share Issuances | $8.81 Million | +334.05% |
| Other Comprehensive Income | $-3.08 Million | -116.69% |
| Other Changes | $3.77 Million | +142.87% |
| Total Change | $- | 218.90% |
Book Value vs Market Value Analysis
This analysis compares Respiri Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 22.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.00x to 22.42x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-06-30 | $254.52 | $0.06 | x |
| 2000-06-30 | $157.60 | $0.06 | x |
| 2001-06-30 | $135.81 | $0.06 | x |
| 2002-06-30 | $19.14 | $0.06 | x |
| 2003-06-30 | $-12.87 | $0.06 | x |
| 2004-06-30 | $1.10 | $0.06 | x |
| 2005-06-30 | $0.99 | $0.06 | x |
| 2006-06-30 | $0.15 | $0.06 | x |
| 2007-06-30 | $0.25 | $0.06 | x |
| 2008-06-30 | $0.25 | $0.06 | x |
| 2009-06-30 | $0.17 | $0.06 | x |
| 2010-06-30 | $0.08 | $0.06 | x |
| 2011-06-30 | $0.05 | $0.06 | x |
| 2012-06-30 | $0.67 | $0.06 | x |
| 2013-06-30 | $0.01 | $0.06 | x |
| 2014-06-30 | $0.03 | $0.06 | x |
| 2015-06-30 | $0.01 | $0.06 | x |
| 2016-06-30 | $0.01 | $0.06 | x |
| 2017-06-30 | $0.00 | $0.06 | x |
| 2018-06-30 | $0.00 | $0.06 | x |
| 2019-06-30 | $0.00 | $0.06 | x |
| 2020-06-30 | $0.00 | $0.06 | x |
| 2021-06-30 | $0.01 | $0.06 | x |
| 2022-06-30 | $0.00 | $0.06 | x |
| 2023-06-30 | $0.00 | $0.06 | x |
| 2024-06-30 | $0.00 | $0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Respiri Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -270.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1560.30%
- • Asset Turnover: 0.07x
- • Equity Multiplier: 2.35x
- Recent ROE (-270.36%) is below the historical average (-210.18%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | -5.72% | 0.00% | 0.00x | 1.07x | $-2.51 Million |
| 2000 | -80.23% | 0.00% | 0.00x | 1.36x | $-6.85 Million |
| 2001 | -65.47% | -17744.90% | 0.00x | 1.12x | $-10.02 Million |
| 2002 | -859.77% | -23260.78% | 0.02x | 1.84x | $-12.00 Million |
| 2003 | 0.00% | -1093.17% | 0.70x | 0.00x | $-4.20 Million |
| 2004 | -19.74% | 0.00% | 0.00x | 1.14x | $-339.67K |
| 2005 | -47.92% | -1395.06% | 0.03x | 1.05x | $-875.31K |
| 2006 | -316.00% | -3655.67% | 0.08x | 1.09x | $-1.27 Million |
| 2007 | -213.13% | -1573.01% | 0.11x | 1.27x | $-5.37 Million |
| 2008 | -240.65% | -11655.79% | 0.02x | 1.19x | $-12.16 Million |
| 2009 | -170.54% | -2972.56% | 0.04x | 1.30x | $-7.09 Million |
| 2010 | -207.20% | -1704.41% | 0.08x | 1.60x | $-6.23 Million |
| 2011 | -316.49% | -2010.71% | 0.10x | 1.59x | $-6.89 Million |
| 2012 | -264.14% | -43068.88% | 0.00x | 1.47x | $-5.80 Million |
| 2013 | -344.16% | -51419.55% | 0.00x | 1.75x | $-5.75 Million |
| 2014 | -113.59% | -54334.42% | 0.00x | 1.17x | $-11.22 Million |
| 2015 | -140.10% | -1092888.60% | 0.00x | 1.33x | $-5.85 Million |
| 2016 | -99.38% | -80768.10% | 0.00x | 1.26x | $-4.41 Million |
| 2017 | -140.30% | -305.48% | 0.31x | 1.47x | $-2.70 Million |
| 2018 | -194.28% | -372.30% | 0.32x | 1.61x | $-3.37 Million |
| 2019 | 0.00% | -727.88% | 1.01x | 0.00x | $-7.31 Million |
| 2020 | -291.05% | -336.89% | 0.47x | 1.85x | $-7.51 Million |
| 2021 | -145.84% | -4087.90% | 0.03x | 1.20x | $-11.80 Million |
| 2022 | -220.24% | -2611.20% | 0.06x | 1.40x | $-6.93 Million |
| 2023 | -698.44% | -8188.07% | 0.02x | 3.85x | $-5.86 Million |
| 2024 | -270.36% | -1560.30% | 0.07x | 2.35x | $-7.39 Million |
Industry Comparison
This section compares Respiri Limited's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Respiri Limited (RSHUF) | $2.64 Million | -5.72% | 1.35x | $59.57 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |